IL-18 GENE PROMOTER REGION 607C/A POLYMORPHISM
IN HIV-1 INFECTED NORTH INDIAN POPULATION
Sobti RC1,*, Sharma VL2, Abitew AM2, Berhane N1,
Mahdi SA1, Askari M1, Kuttiat VS3, Wanchu A3
*Corresponding Author: Ranbir C. Sobti, Department of Biotechnology, Panjab University, Chandigarh 160
014 India; Tel.: +172-2534087; +94-1-704-4523; Fax: +172-25341409; E-mail: rcsobti@ pu.ac.in
page: 41
|
|
REFERENCES
1. Lifson A, Rutherford G, Jaffe J. The natural history of
human immunodeficiency virus infection. J Infect Dis.
1988; 158(6): 1360-1367.
2. Pantaleo G, Fauci AS. Immunopathogenesis of HIV-1
infection. Ann Rev Microbiol. 1996; 50: 825-854.
3. Hogan CM, Hammer SM. Host determinants in HIV
infection and disease. Part 1: cellular and humoral immune
responses. Ann Intern Med. 2001; 134(9, Pt. 1):
761-776.
4. Kaslow RA, Dorak T, and Tang J. Influence of host genetic
variation on susceptibility to HIV type 1 infection.
J Infect Dis. 2005; 191(Suppl. 1): S68-S77.
5. Carrington M, O’Brien SJ. The influence of HLA genotype
on AIDS. Annu Rev Med. 2003; 54: 535-551.
6. Singh P, Gurvinder K, Gaurav S, Narinder KM. Immunogenetic
basis of HIV-1 infection, transmission and
disease progression. Vaccine. 2008; 26(24): 2966-2980.
7. Chatterjee K. Host genetic factors in susceptibility to
HIV-1 infection and progression to AIDS. J Genet.
2010; 89(1): 109-116.
8. Lucey DR, Clerici M, Shearer GM. Type 1 and type 2
cytokine dysregulation in human infectious, neoplastic,
and inflammatory diseases. Clin Microbiol Rev. 1996;
9(4): 532-562.
9. Spilianakis CG, Lalioti MD, Town T, Lee GR, Flavell
RA. Interchromosomal associations between alternatively
expressed loci. Nature. 2005; 435(7042): 637-645.
10. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga
T, McDermott MF, Oksenberg J, McNicholl J, Pociot F,Hardt C, D’Alfonso S. Cytokine gene polymorphism in
human disease: on-line databases, supplement 1. Genes
Immun. 2001; 2(2): 61-70.
11. Dahlman I, Eaves IA, Kosoy R, Morrison VA, Heward
J, Gough SC, Allahabadia A, Franklyn JA, Tuomilehto
J, Tuomilehto-Wolf E, Cucca F, Guja C, Ionescu-Tirgoviste
C, Stevens H, Carr P, Nutland S, McKinney P,
Shield JP, Wang W, Cordell HJ, Walker N, Todd JA,
Concannon P. Parameters for reliable results in genetic
association studies in common diseases. Nat Genet.
2002; 30(2): 149-150.
12. O’Shea JJ, Ma A, Lipsky P. Cytokines and autoimmunity.
Nat Rev Immunol. 2002; 2(1): 37-45.
13. Hill AV. Immunogenetics and genomics. Lancet. 2001;
357(9273): 2037-2041.
14. Nolan KF, Greaves DR, Waldmann H. The human interleukin
18 gene IL-18 maps to 11q22.2-q22.3, closely
linked to the DRD2 gene locus and distinct from
mapped IDDM loci. Genomics. 1998; 51(1): 161-163.
15. Giedraitis V, He B, Huang WX, Hillert J. Cloning and
mutation analysis of the human IL-18 promoter: a possible
role of polymorphisms in expression regulation. J
Neuroimmunol. 2001; 112(1-2): 146-152.
16. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H.
Interleukin-18 regulates both Th1 and Th2 responses.
Annu Rev Immunol. 2001; 19: 423-474.
17. Gracie JA, Robertson SE, McInnes IB. Interleukin-18.
J Leukocyte Biol. 2003; 73(2): 213-224.
18. Shapiro L, Puren AJ, Barton HA, Novick D, Peskind
RL, Shenkar R, Gu Y, Su MS-S, Dinarello CA. Interleukin
18 stimulates HIV type 1 in monocytic cells. Proc
Natl Acad Sci USA. 1998; 95(21): 12550-12555.
19. Klein SA, Klebba C, Kauschat D, Pape M, Ozmen
L, Hoelzer D, Ottmann OG, Kalina U. Interleukin-18
stimulates HIV-1 replication in a T-cell line. Eur Cytokine
Netw. 2000; 11(1): 47-52.
20. Torre D, Speranza F, Martegani R, Pugliese A, Castelli
F, Basilico C, Biondi G. Circulating levels of IL-18
in adult and paediatric patients with HIV-1 infection.
AIDS. 2000; 14(14): 2211-2212.
21. Wiercinska-Drapalo A, Jaroszewicz J, Flisiak R, Prokopowicz
D. Plasma interleukin-18 is associated with viral
load and disease progression in HIV-1-infected patients.
Microbes Infect. 2004; 6(14): 1273-1277.
22. Stylianou E, Bjerkeli V, Yndestad A, Heggelund L,
Waehre T, Damas JK, Wachre T, Damas JK, Aukrust P,
Froland SS. Raised serum levels of interleukin-18 is associated
with disease progression and may contribute to
virological treatment failure in HIV-1-infected patients.
Clin Exp Immunol. 2003; 132(3): 462-466.
23. Sakai K, Kita M, Sawai N, Shiomi S, Sumida Y, Kanemasa
K, Mitsufuji S, Imamichi J, Yamaoka Y. Levels of
interleukin-18 are markedly increased in Helicobacter
pylori-infected gastric mucosa among patients with
specific IL18 genotypes. J Infect Dis. 2008; 197(12):
1752-1761.
24. Xu Q, Tin SK, Sivalingam SP, Thumboo J, Koh DR,
Fong KY. Interleukin-18 promoter gene polymorphisms
in Chinese patients with systemic lupus erythematosus:
association with CC genotype at position –607. Ann
Acad Med.2007; 36(2): 91-95.
25. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning:
A Laboratory Manual. Cold Spring Harbor: Cold
Spring Harbor Laboratory. 1989:E3-E5.
26. Sobti RC, Nega B, Salih AM, Rupinder K, Seyed AH,
Vijesh K, Ajay W. Polymorphisms of IL-6 174 G/C, IL-
10 –592 C/A and risk of HIV/AIDS among North Indian
population. Mol Cell Biochem. 2009; 337(1-2): 145-152.
27. Sobti RC, Salih AM, Nega B, Seyed AH, Rupinder K,
Vijesh K, Ajay W. Insights into the role of IL-12B and
IFN-γ cytokine gene polymorphisms in HIV-1/AIDS infection.
Folia Biologica (Praha). 2010; 56(3): 110-115.
28. Dinarello CA, Fantuzzi G. Interleukin-18 and host defense
against infection. J Infect Dis. 2003; 187(Suppl.
2): S370-S384.
29. Skurk T, Kolb H, Muller-Scholze S, Rohrig K, Hauner
H, Herder C. The proatherogenic cytokine interleukin-
18 is secreted by human adipocytes. Eur J Endocrinol.
2005; 152(6): 863-868.
30. Iannello A, Samarani S, Debbeche O, Tremblay C,
Toma E, Boulassel M-R, Routy J-P, Ahmad A. Role of
interleukin-18 in the development and pathogenesis of
AIDS. AIDS Rev. 2009; 11(3): 115-125.
31. Pugliese A, Gennero L, Vidotto V, Speranza F, Tambini
R, Torre D. Interleukin-18 enhances HIV-1 production
in a human chronically-infected T cell line (H9-V). Cell
Biochem Funct. 2002; 20(4): 333-337.
32. Song W, Wilson CM, Allen S, Wang C, Li Y, Kaslow
RA, Tang J. Interleukin 18 and human immunodeficiency
virus type I infection in adolescents and adults. Clin
Exp Immunol. 2006; 144(1): 117-124.
33. Segat L, Bevilacqua D, Boniotto M, Arraes LC, de Souza
PR, de Lima Filho JL, Crovella S. IL-18 gene promoter
polymorphism is involved in HIV-1 infection in a
Brazilian pediatric population. Immunogenetics. 2006;
58(5-6): 471-473.
|
|
|
|
 |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
|
